BC is categorized the following established criteria: tumor morphology, grade, stage, and expression of key genes, such as estrogen receptor-α (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2 or ERBB2), to determine adequate treatment options. Here, ERBB2 is linked to neoplasm.